CaringAI Presents Research at AAIC 2026 Showing Strong Clinician Agreement with AI-Powered Telephone Cognitive Screening
Study evaluated CaringAI Listen in real-world primary care in a predominantly Black patient population, a group that has been historically underrepresented in Alzheimer's research.
CaringAI, a healthcare technology company building an AI-powered voice agent platform for patient engagement, cognitive assessment, and dementia care, today announced research presented at the Alzheimer's Association International Conference (AAIC) 2026— the world's largest dementia research conference— in London. The study evaluates clinician agreement with CaringAI Listen, the company's telephone-based AI cognitive assessment platform, in real-world primary care and reports substantial agreement between AI-administered and scored assessments and independent clinical review.
Cognitive impairment remains significantly underdetected in primary care. Fewer than one in ten expected cases of mild cognitive impairment are identified by primary care providers, leaving approximately 90% of cases unrecognized. Primary care is where most older adults are seen and where cognitive concerns surface first, but clinicians consistently cite limited time as the primary barrier to screening. CaringAI Listen is designed to close that gap: a conversational voice agent that conducts validated cognitive assessments by phone, requiring no app, device, or patient setup.
